These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18785587)

  • 1. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
    Ou X; Dai X; Long Z; Tang Y; Cao D; Hao X; Hu Y; Li X; Tang C
    Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of T0901317 on hepatic proinflammatory gene expression in apoE-/- mice fed a high-fat/high-cholesterol diet.
    Dai X; Ou X; Hao X; Cao D; Tang Y; Hu Y; Li X; Tang C
    Inflammation; 2007 Aug; 30(3-4):105-17. PubMed ID: 17516158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
    J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic liver X receptor agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apolipoprotein E knockout mice.
    Dai X; Ou X; Hao X; Cao D; Tang Y; Hu Y; Li X; Tang C
    Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):261-8. PubMed ID: 18330481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317.
    Peng D; Hiipakka RA; Reardon CA; Getz GS; Liao S
    Atherosclerosis; 2009 Mar; 203(1):59-66. PubMed ID: 18639878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
    Peng D; Hiipakka RA; Dai Q; Guo J; Reardon CA; Getz GS; Liao S
    J Pharmacol Exp Ther; 2008 Nov; 327(2):332-42. PubMed ID: 18723776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
    van der Stoep M; Li Z; Calpe-Berdiel L; van der Sluis RJ; Saleh P; McKinnon HJ; Smit MJ; Korporaal SJ; Van Berkel TJ; Van Eck M; Hoekstra M
    Biochem Pharmacol; 2013 Dec; 86(11):1594-602. PubMed ID: 24095721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
    Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
    J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
    Zhang X; Zhu Z; Luo G; Zheng L; Nilsson-Ehle P; Xu N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):114-7. PubMed ID: 18413148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice.
    Hoekstra M; de Jong LM; van der Geest R; de Leeuw LR; Krisnamurthi R; Geerling JJ; Van Eck M
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid transfer protein is regulated by liver X receptors in vivo.
    Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC
    J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
    Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
    Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Hu YW; Mo ZC; Li XX; Liu XH; Xiao J; Yin WD; Liao DF; Tang CK
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):199-206. PubMed ID: 19229602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T0901317, an LXR agonist, augments PKA-induced vascular cell calcification.
    Hsu JJ; Lu J; Huang MS; Geng Y; Sage AP; Bradley MN; Tontonoz P; Demer LL; Tintut Y
    FEBS Lett; 2009 Apr; 583(8):1344-8. PubMed ID: 19327357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.